Pyridines, pyrimidines, and pyrazines, as BTK inhibitors and uses thereof
US9738648B2 · kind B2 · utility
1Cited by
8References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 30, 2014 |
| Grant date | Aug 22, 2017 |
| Priority date | — |
| Expiry date | Jul 30, 2034 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to pyridine, pyrimidine, and pyrazine compounds, and pharmaceutically acceptable compositions thereof, useful as BTK inhibitors.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.